Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
Mereo Biopharma Group Plc ADR (NASDAQ: MREO) closed the day trading at $1.95 down -2.99% from the previous closing price of $2.01. In other words, the price has decreased by -$2.99 from its previous closing price. On the day, 1.41 million shares were traded. MREO stock price reached its highest trading level at $2.0197 during the session, while it also had its lowest trading level at $1.92.
Ratios:
For a better understanding of MREO, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.13 and its Current Ratio is at 8.13. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, JP Morgan on March 27, 2025, initiated with a Overweight rating and assigned the stock a target price of $7.
On December 06, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $7.
On June 13, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $8.Robert W. Baird initiated its Outperform rating on June 13, 2024, with a $8 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MREO now has a Market Capitalization of 310238912 and an Enterprise Value of 1495670528. For the stock, the TTM Price-to-Sale (P/S) ratio is 607.94 while its Price-to-Book (P/B) ratio in mrq is 5.72. Its current Enterprise Value per Revenue stands at 2991.341 whereas that against EBITDA is -33.985.
Stock Price History:
The Beta on a monthly basis for MREO is 0.36, which has changed by -0.5289855 over the last 52 weeks, in comparison to a change of 0.15927899 over the same period for the S&P500. Over the past 52 weeks, MREO has reached a high of $4.72, while it has fallen to a 52-week low of $1.47. The 50-Day Moving Average of the stock is 10.46%, while the 200-Day Moving Average is calculated to be -18.60%.
Shares Statistics:
Over the past 3-months, MREO traded about 2.26M shares per day on average, while over the past 10 days, MREO traded about 1574880 shares per day. A total of 159.00M shares are outstanding, with a floating share count of 131.27M. Insiders hold about 17.44% of the company’s shares, while institutions hold 51.99% stake in the company. Shares short for MREO as of 1757894400 were 11042078 with a Short Ratio of 4.89, compared to 1755216000 on 10490546. Therefore, it implies a Short% of Shares Outstanding of 11042078 and a Short% of Float of 9.7600006.
Earnings Estimates
The market rating of Mereo Biopharma Group Plc ADR (MREO) is currently shaped by the ongoing analysis conducted by 6.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.0, with high estimates of $0.04 and low estimates of -$0.01.
Analysts are recommending an EPS of between $0.04 and -$0.05 for the fiscal current year, implying an average EPS of -$0.03. EPS for the following year is -$0.03, with 5.0 analysts recommending between $0.04 and -$0.05.
